Concurrent Gemcitabine Chemotherapy and 3D-CRT for Elderly Advanced Non-small Cell Lung Cancer
-
Graphical Abstract
-
Abstract
Objective To evaluate the therapeutic effectiveness and adverseevents of concurrent gemcitabine chemotherapy and 3-dimentional conformalradiotherapy (3D-CRT) for elderly advanced non-small cell lung cancer(NSCLC). Methods 65 patients of stage Ⅲ NSCLC were enrolled into twogroups: 35cases in the treatment group received concurrent chemotherapy(gemcitabine 1000mg/m2/w, continuous 3 weeks) and 3D-CRT: were given,(3~4)Gyper fractions,5 fraction a week,to total dose of (40~52) Gy/(3~4) week.30 casesin the control...
-
-